Evidence map›Paper›PMID 25026622›Full record

ArticleInfection control and hospital epidemiology2014

Effectiveness of screening hospital admissions to detect asymptomatic carriers of Clostridium difficile: a modeling evaluation.

Cristina Lanzas, Erik R Dubberke

Open access · greenAbstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Infection control and hospital epidemiology · 2023
    Article
  7. Article
  8. Estimating the effect of active detection and isolation onInfection control and hospital epidemiology · 2023
    Article
  9. Review
  10. Article
  11. Review
  12. Canadian journal of gastroenterology & hepatology · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Cristina LanzasDepartment of Biomedical and Diagnostic Sciences, University of Tennessee, Knoxville, Tennessee.
Erik R Dubberke
University of Tennessee at Knoxville · USWashington University in St. Louis · US

Funding

FOOD & WATERBORNE DISEASES INTEGRATED RESEARCH NETWORKN01AI30054 · NIAID · CORNELL UNIVERSITY · PI GROHN, YRJO · 2007 to 2009
$2.9M
C. DIFFICILE DISEASE IN STEM CELL TRANSPLANT RECIPIENTSK23AI065806 · NIAID · WASHINGTON UNIVERSITY · PI DUBBERKE, ERIK R · 2009 to 2011
$374k
FOOD &WATERBORNE DISEASES INTEGRATED RESEARCH NETWORK, ZOONOES RESEAR-N01AI030054 · NIAID · CORNELL UNIVERSITY · 2003 to 2003
–
NCEZID CDC HHS 1U54CK000162NCEZID CDC HHS U54 CK000162NIAID NIH HHS K23 AI065806NIAID NIH HHS K23AI065806NIAID NIH HHS N01 AI030054NIAID NIH HHS N01AI30054
6 · The paper itself

Abstract

objectiveBoth asymptomatic and symptomatic Clostridium difficile carriers contribute to new colonizations and infections within a hospital, but current control strategies focus only on preventing transmission from symptomatic carriers. Our objective was to evaluate the potential effectiveness of methods targeting asymptomatic carriers to control C. difficile colonization and infection (CDI) rates in a hospital ward: screening patients at admission to detect asymptomatic C. difficile carriers and placing positive patients into contact precautions.

methodsWe developed an agent-based transmission model for C. difficile that incorporates screening and contact precautions for asymptomatic carriers in a hospital ward. We simulated scenarios that vary according to screening test characteristics, colonization prevalence, and type of strain present at admission.

resultsIn our baseline scenario, on average, 42% of CDI cases were community-onset cases. Within the hospital-onset (HO) cases, approximately half were patients admitted as asymptomatic carriers who became symptomatic in the ward. On average, testing for asymptomatic carriers reduced the number of new colonizations and HO-CDI cases by 40%-50% and 10%-25%, respectively, compared with the baseline scenario. Test sensitivity, turnaround time, colonization prevalence at admission, and strain type had significant effects on testing efficacy.

conclusionsTesting for asymptomatic carriers at admission may reduce both the number of new colonizations and HO-CDI cases. Additional reductions could be achieved by preventing disease in patients who are admitted as asymptomatic carriers and developed CDI during the hospital stay.

Indexed as

Clostridioides difficilePatient AdmissionAsymptomatic InfectionsClostridium InfectionsCross InfectionFemaleHumansMaleMiddle AgedModels, TheoreticalPrevalence

Identifiers

PMID25026622
PMCPMC13007263
OpenAlexW2165188084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.